ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

LPTX Leap Therapeutics Inc

3,17
-0,10 (-3,06%)
Après les heures de négociation
Dernière mise à jour : 22:30:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Leap Therapeutics Inc LPTX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,10 -3,06% 3,17 22:30:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,31 3,05 3,35 3,17 3,27
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
11/4/202414:30PRNUSLeap Therapeutics Announces $40 Million Private Placement
18/3/202412:00PRNUSLeap Therapeutics Reports Fourth Quarter and Full Year 2023..
01/2/202403:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202402:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202402:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202423:21EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/1/202423:28EDGAR2Form 8-K - Current report
16/1/202423:10EDGAR2Form 8-K - Current report
16/1/202423:05PRNUSLeap Therapeutics to Present New Clinical Data from Part A..
03/1/202413:00PRNUSLeap Therapeutics to Participate at the 42nd Annual J.P...
02/1/202413:00PRNUSLeap Therapeutics Announces Completion of Enrollment in..
12/12/202322:02EDGAR2Form 8-K - Current report
11/12/202322:05PRNUSLeap Therapeutics to Present New Data from Part A of the..
21/11/202313:00PRNUSLeap Therapeutics to Participate at Piper Sandler 35th..
13/11/202313:10EDGAR2Form 8-K - Current report
13/11/202313:00PRNUSLeap Therapeutics Reports Third Quarter 2023 Financial..
13/11/202312:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/9/202320:44EDGAR2Form 8-K - Current report
05/9/202313:00PRNUSLeap Therapeutics to Participate at Upcoming Investor..
30/8/202322:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
25/8/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202313:10EDGAR2Form 8-K - Current report
14/8/202313:00PRNUSLeap Therapeutics Reports Second Quarter 2023 Financial..
14/8/202312:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/7/202313:10EDGAR2Form 8-K - Current report
12/7/202313:00PRNUSLeap Therapeutics Announces Initiation of Randomized..
20/6/202318:30PRNUSLeap Therapeutics Announces Reverse Stock Split
25/5/202323:10PRNUSLeap Therapeutics to Present Updated Data from Part A of the..
15/5/202313:00PRNUSLeap Therapeutics Reports First Quarter 2023 Financial..

Dernières Valeurs Consultées

Delayed Upgrade Clock